These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34419519)

  • 41. Diagnosis and treatment of osteoporosis in chronic renal disease.
    Miller PD
    Semin Nephrol; 2009 Mar; 29(2):144-55. PubMed ID: 19371805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uremic Toxicity and Bone in CKD.
    Yamamoto S; Fukagawa M
    J Nephrol; 2017 Oct; 30(5):623-627. PubMed ID: 28573386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors and renal outcomes of low bone mineral density in patients with non-dialysis chronic kidney disease.
    Hyun YY; Lee KB; Han SH; Choi KH; Park HC; Oh YK; Park SK; Oh KH; Ahn C;
    Osteoporos Int; 2020 Dec; 31(12):2373-2382. PubMed ID: 32642852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of biochemical markers and bone mineral density in patients with chronic kidney disease stage 5D at the start of hemodialysis treatment.
    Valkovsky I; Olsanska R; Tvrdik J; Martinek A; Svagera Z; Pernicova M; Dedochova J; Cermakova Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):93-9. PubMed ID: 24322342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of osteoporosis in CKD Stages 3 to 5.
    Gordon PL; Frassetto LA
    Am J Kidney Dis; 2010 May; 55(5):941-56. PubMed ID: 20438987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic kidney disease and fragility fracture.
    Kazama JJ
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D.
    Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust MH; Prieto-Alhambra D; Torres PU; Cannata-Andia J;
    Nephrol Dial Transplant; 2021 Jan; 36(1):42-59. PubMed ID: 33098421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
    Fidan N; Inci A; Coban M; Ulman C; Kursat S
    J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
    Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
    BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.
    Sit D; Kadiroglu AK; Kayabasi H; Atay AE; Yilmaz Z; Yilmaz ME
    Adv Ther; 2007; 24(5):987-95. PubMed ID: 18029324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum osteocalcin concentration as an independent biomarker of osteoporosis in patients with chronic kidney disease.
    Chi PJ; Hung SY; Hsiao FT; Liou HH; Tsai JP
    Clin Nephrol; 2022 Jul; 98(1):1-9. PubMed ID: 35445659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoporosis, bone mineral density and CKD-MBD (II): Therapeutic implications.
    Bover J; Ureña-Torres P; Laiz Alonso AM; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Benito S; López-Báez V; Lloret Cora MJ; Cigarrán S; DaSilva I; Sánchez-Bayá M; Mateu Escudero S; Guirado L; Cannata-Andía J
    Nefrologia (Engl Ed); 2019; 39(3):227-242. PubMed ID: 30797619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteoporosis in the elderly with chronic kidney disease.
    Ersoy FF
    Int Urol Nephrol; 2007; 39(1):321-31. PubMed ID: 17103030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Pérez-Sáez MJ; Herrera S; Prieto-Alhambra D; Vilaplana L; Nogués X; Vera M; Redondo-Pachón D; Mir M; Güerri R; Crespo M; Díez-Pérez A; Pascual J
    Osteoporos Int; 2017 Sep; 28(9):2723-2727. PubMed ID: 28497224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.
    Orlic L; Crncevic Z; Pavlovic D; Zaputovic L
    Ren Fail; 2010 Jan; 32(3):300-8. PubMed ID: 20370444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of bone turnover markers in chronic kidney disease-mineral and bone disorders.
    Chiang C
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():11-13. PubMed ID: 28429547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone alkaline phosphatase in CKD-mineral bone disorder.
    Sardiwal S; Magnusson P; Goldsmith DJ; Lamb EJ
    Am J Kidney Dis; 2013 Oct; 62(4):810-22. PubMed ID: 23623575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
    Pocock N
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can one evaluate bone disease in chronic kidney disease without a biopsy?
    Babayev R; Nickolas TL
    Curr Opin Nephrol Hypertens; 2014 Jul; 23(4):431-7. PubMed ID: 24867672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.